bioRxivDevelopmental BiologyPreprint
The distinct effects of MEK and GSK3 inhibition upon the methylome and transcriptome of mouse embryonic stem cells
Julia SpindeliD, Christel KruegeriD, Felix KruegeriD, Evangelia K. PapachristouiD, Kamal KishoreiD, Clive S. D’SantosiD, Wolf ReikiD
Abstract
Mouse embryonic stem cells (mESCs) were first cultured in vitro in serum-containing medium with leukaemia inhibitory factor, in which they exhibit heterogeneous expression of both pluripotency and some early differentiation markers. Over the last decade, however, it has become commonplace to grow mESCs with inhibitors of MEK and GSK3 signalling, which together elicit a more homogeneously naive state of pluripotency. Whilst 2i/L-cultured mESCs have been shown to be globally hypomethylated, a comprehensive understanding of the distinct effects of these signalling inhibitors upon the DNA methylome is still lacking. Here we carried out whole genome bisulphite and RNA sequencing of mESCs grown with MEK or GSK3 inhibition alone, including different time points and concentrations of MEK inhibitor treatment. This demonstrated that MEK inhibition causes a dose-dependent impairment of maintenance methylation via loss of UHRF1 protein, as well as rapid impairment of de novo methylation. In contrast, GSK3 inhibition triggers impairment of de novo methylation alone, and consequent hypomethylation is enriched at enhancers with a 2i/L-specific chromatin signature and coincides with upregulation of nearby genes. Our study provides detailed insights into the epigenetic and transcriptional impacts of inhibiting MEK or GSK3 signalling in mouse pluripotent cells. HighlightsO_LIMEK inhibition causes dose-dependent impairment of maintenance methylation via loss of UHRF1 protein, as well as impairment of de novo methylation. C_LIO_LIGSK3 inhibition triggers impairment of de novo methylation alone, which results in hypomethylation of enhancers and non-CGI promoters. C_LIO_LIEnhancers that are hypomethylated following GSK3 inhibition are enriched for 2i/L-specific pluripotency factor binding, TET2 and H3K4me1. C_LIO_LIEnhancer hypomethylation coincides with increased expression of nearby and Capture Hi-C linked genes. C_LI
- organism: mouse
- assay: DNA methylation
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mouse Embryonic Stem Cell Pluripotency Factors Regulate RNA Methylation
Laura J. Sedivy, Gabrielle Brandt, … Christopher J. Phiel·bioRxiv·Feb 23, 2023
- DNA methylation is indispensable for leukemia inhibitory factor dependent embryonic stem cells reprogramming
- The DNMT1 inhibitor GSK-3484862 mediates global demethylation in murine embryonic stem cells
Nathália Azevedo Portilho, Deepak Saini, … William A. Pastor·Epigenetics & ChromatinPeer-reviewed·Dec 1, 2021
- Genetic variation influences pluripotent ground state stability in mouse embryonic stem cells through a hierarchy of molecular phenotypes
Daniel A. Skelly, Anne Czechanski, … Laura G. Reinholdt·bioRxiv·Feb 17, 2019
- MLL3/MLL4 methyltransferase activities control early embryonic development and embryonic stem cell differentiation in a lineage-selective manner
Guojia Xie, Ji‐Eun Lee, … Kai Ge·Nature GeneticsPeer-reviewed·Apr 1, 2023
- Vitamin C and Transferrin Reduce RNA Methylation in Mouse Embryonic Stem Cells
Gabrielle Brandt, Laura J. Sedivy, … Christopher J. Phiel·bioRxiv·Feb 23, 2023